Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899866-13-000128)

Filing Details

Accession Number:: 0000899866-13-000128
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-07-16 16:44:53
Reporting Period:: 2013-07-12

Filing Date:: 2013-07-16
Accepted Time:: 2013-07-16 16:44:53
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
899866	Alexion Pharmaceuticals Inc	ALXN	Pharmaceutical Preparations (2834)	133648318

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1457477	David Hallal	C/O Alexion Pharmaceuticals, Inc 352 Knotter Drive Cheshire CT 06410	Evp, Chief Commercial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $.0001 Per Share	Acquisiton	2013-07-12	50,000	$17.65	139,654	No	4	M	Direct
Common Stock, Par Value $.0001 Per Share	Disposition	2013-07-12	50,000	$120.00	89,654	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock, Par Value $.0001 Per Share	Option to Purchase Common Stock	Disposition	2013-07-12	50,000	$17.65	50,000	$17.65

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
14,336	2008-04-09	2018-01-09	No	4	M	Direct

Footnotes

The transactions reported by this Form 4 are made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act.